17
To Prevent Selection Bias Wenle Zhao, PhD Medical University of South Carolina, Charleston, SC, 29425, USA Society for Clinical Trials 36th Annual Meeting Arlington, VA, USA - May 17-20, 2015 Minimal Balance is Sufficient

To Prevent Selection Bias Wenle Zhao, PhD Medical University of South Carolina, Charleston, SC, 29425, USA Society for Clinical Trials 36th Annual Meeting

Embed Size (px)

Citation preview

To Prevent Selection Bias

Wenle Zhao, PhD

Medical University of South Carolina, Charleston, SC, 29425, USA

Society for Clinical Trials 36th Annual MeetingArlington, VA, USA - May 17-20, 2015

Minimal Balance is Sufficient

Contents

1. Where does Selection Bias Come From?

2. How to prevent selection bias?

3. How to avoid random serious imbalance?

The Worst Thing in the World of Clinical Trials

Funding?Recruitment?

A Completed Trial with Suspicious SELECTION BIAS.

Defense Measurements against Selection Bias

Random Allocation

Allocation Concealment

Treatment Masking

Subject Enrollmen

t

Treatment Allocation

Outcome Assessme

nt

Real-time Subject

Randomization

The only reliable protection left against selection bias.

Allocation Randomness

1, , , i i iT F R W T X

Target allocation ratio

To balance treatment distributionPermuted Block Randomization

Biased Coin, Urn Design

Random variable ~U(0,1)

To balance baseline covariateStratified Randomization

Minimization

Allo

cati

on R

and

om

ness

Complete Randomization

Permuted BlockRandomization

Minimization

Predictability Defeats Concealment & Masking

Pr( ) 1iT A Deterministic Assignment

50

%

Pro

port

ion o

f D

A

100%

B = 2

33

%

B = 4

25 %

B = 6Permuted Block

Randomization

~ 8

7%

Minimization

2 0 %B =

8

0

Evidence of Selection Bias in Randomized Trials 1. Heparin for myocardial

infarction2. University Group Diabetes Program3. Talc and mustine for pleural

effusions4. Tonsillectomy for recurrent throat infection in children5. Oxytocin and amniotomy for induction of

labor6. Western Washington Intracoronary Streptokinese Trial7. RSV immune globulin in infants and young

children8. A trial to assess episiotomy9. Canadian National Breast Cancer Screening Study10. Surgical Trial11. Lifestyle Heart Trial

12. Coronary Artery Surgery Trial 13. Etanercept for children with juvenile rheumatoid arthritis14. Edinburgh Randomized Trial of Breast Cancer

Screening15. Captopril Prevention Project

16. Göteborg (Swedish) Mammography Trial

17. HIP Mammography Trial18. Hypertension Detection and Follow-up Program

19. Randomized Trial to prevent vertical transmission of HIV-1

20. Effectiveness trial of diagnostic test21. S African trial of high-dose chemotherapy for metastatic breast cancer22. Randomized study of a culturally sensitive AIDS education

program23. Runaway Youth Study24. Cluster randomized trial of palliative care25. Randomized trial of methadone with or without

heroin26. Randomized NINDS trial of tissue plasminogen activator for acute ischemic stroke27. Norwegian Timolol

Trial 28. Laparoscopic versus open appendectomy

29. The Losartan Intervention for Endpoint reduction in Hypertension Study30. The Heart Outcomes Prevention Evaluation

Study

EE

PP

PP

P

EE

PP

EP

EP

PE

EP

P

PE

PP

PP

PP

PP

E Selection bias

evidence identified

P Suspicious election bias

due to p-value <

0.05

Protect Trials Against Selection Bias

P < 0.05 ?

P > 0.2

P > 0.3

Selection bias will result small p-values

Complete randomization may (5% chance) see a p-value < 0.05

The Logic

Real-time complete randomization Eliminates selection bias due to allocation

predictability Eliminates selection bias due to allocation concealment

failure Totally eliminates selection bias Without selection bias, complete randomization may still

have Imbalance in treatment distribution

Power loss is trivial Imbalance is baseline covariate distribution

Adjustment, not balancing, is the solution Serious baseline covariate imbalance with p-value <

0.05 5% chance for any covariate 60% chance for at least one in 10

covariates Suspicion of selection bias Trouble in trial result interpretation

Options We HaveStratified Restricted Randomization

Permuted Block Randomization Biased Coin Design - Efron Urn Design - Wei Big Stick Design – Soares & Wu Maximal Procedure – Berger et al. Block Urn Design – Zhao & Weng

Unnecessarily tighten control imbalances.

Disabled when number of strata getting large.

Minimization

Most assignments are deterministic.

Dynamic Hierarchy Balancing

Hierarchy order is hard to justify.

Minimal Sufficient Balance Procedure

Subject ready for randomization

Any serious imbalance?

Current assignment can effectively

reduce imbalances?

Complete randomization Biased coin assignment

Next subject

N

N

Y

Y

Any p-value < 0.2?

The proportion depends on p-

value threshold and biased coin

probability

T-test for continuous var.

χ2 test for categorical var.

p-value Site NIHSS Age OTT GlucoseStroke

SubtypeSex Fibrinogen Weight

Systolic BP

Diastolic BP

Observed in the Original Study

0.9987

0.1398

0.0289

0.8662

0.7804 0.07330.626

50.1808

0.0111

0.5968 0.2810

Serious imbalances found in 2 of the 11 baseline covariates.

Example : NINDS rt-PA Stroke Study

Example : NINDS rt-PA Stroke Study

NINDS rt-PA Stroke study data. Simulations = 5000

Baseline covariates:• Severity (NIHSS)• Age• Onset to treat• Glucose• Center

Distribution of p-Values for baseline covariate imbalance tests with 11 covariates controlled*NINDS rt-PA data, Imbalance control limit p-Value ≥ 0.3. ξ= 0.65, simulation = 1000/scenario.

p-value Site NIHSS Age OTT GlucoseStroke

SubtypeSex Fibrinogen Weight

Systolic BP

Diastolic BP

Low 2.5% boundary

0.226 0.259 0.237 0.262 0.244 0.262 0.214 0.245 0.239 0.252 0.246

Low 5% boundary

0.276 0.295 0.279 0.288 0.280 0.292 0.277 0.288 0.278 0.281 0.287

Low 10% boundary 0.309 0.341 0.316 0.323 0.315 0.326 0.309 0.322 0.319 0.322 0.330

Median 0.605 0.631 0.626 0.624 0.624 0.638 0.609 0.634 0.626 0.638 0.610

Observed in the Original Study

0.9987

0.1398

0.0289

0.8662

0.7804 0.07330.626

50.1808

0.0111

0.5968 0.2810

Balance 11 baseline covariates

Example : NINDS rt-PA Stroke Study

Summary

Complete randomization eliminates selection bias due to allocation predictability.

Real-time randomization eliminates selection bias due to allocation concealment failures.

Minimization method has the highest proportion of deterministic assignments, and therefore is vulnerable to selection bias.

Power loss due to treatment imbalance is trivial.

Justification, not balancing, is the solution for covariate confounding effects.

Using Minimal Sufficient Balancing to prevent random serious imbalances, while maintaining a high level of allocation randomness.

Thank You!Contact me at:

[email protected]

Some of my works on Randomization

.

Zhao W. A better alternative to stratified permuted block design for subject randomization in clinical trials. Stat Med. 2014 Dec 30;33(30):5239-48. doi: 10.1002/sim.6266. PMID: 25043719

Zhao W. Selection bias, allocation concealment and randomization design in clinical trials. Contemp Clin Trials. 2013 Sep;36(1):263-5. doi: 10.1016/j.cct.2013.07.005. Epub 2013 Jul 19. No abstract available. PMID: 23871796

Zhao W, Weng Y. Block urn design - a new randomization algorithm for sequential trials with two or more treatments and balanced or unbalanced allocation. Contemp Clin Trials. 2011 Nov;32(6):953-61. doi: 10.1016/j.cct.2011.08.004. PMID: 21893215

Zhao W, Hill MD, Palesch Y. Minimal sufficient balance--a new strategy to balance baseline covariates and preserve randomness of treatment allocation. Stat Methods Med Res. 2012 Jan 26. [Epub ahead of print] PMID: 22287602

Zhao W, Ciolino J, Palesch Y. Step-forward randomization in multicenter emergency treatment clinical trials. Acad Emerg Med. 2010 Jun;17(6):659-65. doi: 10.1111/j.1553-2712.2010.00746.x. PMID: 20624149

Zhao W, Weng Y, Wu Q, Palesch Y. Quantitative comparison of randomization designs in sequential clinical trials based on treatment balance and allocation randomness. Pharm Stat. 2012 Jan-Feb;11(1):39-48. doi: 10.1002/pst.493. PMID: 21544929

Zhao W, Durkalski V. Managing competing demands in the implementation of response-adaptive randomization in a large multicenter phase III acute stroke trial. Stat Med. 2014 Oct 15;33(23):4043-52. doi: 10.1002/sim.6213. Epub 2014 May 22. PMID: 24849843

Zhao W, Mu Y, Tayama D, Yeatts SD. Comparison of statistical and operational properties of subject randomization procedures for large multicenter clinical trial treating medical emergencies. Contemp Clin Trials. 2015 Mar;41:211-8. doi: 10.1016/j.cct.2015.01.013. Epub 2015 Jan 29. PMID: 25638754